Oncogene

Oncology & Cancer

Cannabinoid improves survival rates of mice with pancreatic cancer

Mice with pancreatic cancer that were treated with a naturally occurring constituent of medicinal cannabis alongside chemotherapy, survived almost three times longer than those treated with chemotherapy alone, a new study ...

Oncology & Cancer

Study shows role of enzyme in prostate cancer growth

A new USC School of Pharmacy study led by University Professor Jean Chen Shih offers new evidence that the monoamine oxidase-A enzyme (MAO-A) pathway could be an important target in treating prostate cancer.

Oncology & Cancer

Tumor-like spheres help scientists discover smarter cancer drugs

May 14, 2018—Cancer is a disease often driven by mutations in genes. As researchers learn more about these genes, and the proteins they code for, they are seeking smarter drugs to target them. The ultimate goal is to find ...

Oncology & Cancer

Targeting telomerase as therapeutic strategy for melanoma

Targeting telomerase was effective at killing NRAS-mutant melanoma cells, and the impact was further enhanced when the strategy was paired with an inhibitor of mitochondrial function, according to study results by The Wistar ...

Oncology & Cancer

Combination of medications slows down brain tumours in children

In collaboration with a number of American colleagues, researchers from Uppsala University have found an Achilles' heel for the most common form of malignant child brain tumours. By combining two kinds of medicines, it is ...

Oncology & Cancer

Why asbestos is so dangerous

The fact that asbestos causes cancer has been largely undisputed for nearly 50 years. Now, researchers supported by the Swiss National Science Foundation (SNSF) have discovered why the fibres cause such damage to the body. ...

page 6 from 18